...
首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Involvement of N-methyl-D-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test
【24h】

Involvement of N-methyl-D-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test

机译:N-甲基-D-天冬氨酸受体参与5-羟色胺3拮抗剂的抗抑郁样作用在小鼠强迫游泳试验和尾巴悬吊试验中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Recent evidence indicates that 5-hydroxytryptamine 3 (5-HT3) antagonists such as ondansetron and tropisetron exert positive behavioral effects in animal models of depression. Due to the ionotropic nature of 5-HT3 and N-methyl-D-aspartate (NMDA) receptors, plus their contribution to the pathophysiology of depression, we investigated the possible role of NMDA receptors in the antidepressant -likeeffect of 5-HT3 receptor antagonists in male mice. In order to evaluate the animals' behavior in response to different treatments, we performed open-field test (OFT), forced swimming test (FST), and tail-suspension test (TST), which are considered as valid tasks for measuring locomotor activity and depressive-like behaviors in mice. Our data revealed that intraperitoneal (i.p.) administration of tropisetron (5,10, and 30 mg/kg) and ondansetron (0.01, and 0.1 mu g/kg) significantly decreased the immobility time in FST and TST. Also, co-administration of subeffective doses of tropisetron (1 mg/kg, i.p.) or ondansetron (0.001 mu g/kg, i.p.) with subeffective doses of NMDA receptor antagonists, ketamine (1 mg/kg, i.p.), MK-801 (0.05 mg/kg, i.p.) and magnesium sulfate (10 mg/kg, i.p.) resulted in a reduced immobility time both in FST and TST. The subeffective dose of NMDA (NMDA receptor agonist, 75 mg/kg, i.p.) abolished the effects of 5-HT3 antagonists in FST and TST, further supporting the presumed interaction between 5-HT3 and NMDA receptors. These treatments did not affect the locomotor behavior of animals in OFT. Finally, the results of our study suggest that the positive effects of 5-HT3 antagonists on the coping behavior of mice in FST and TST are at least partly mediated through NMDA receptors participation. (C) 2015 Elsevier Inc. All rights reserved.
机译:最近的证据表明,5-羟色胺3(5-HT3)拮抗剂(如ondansetron和tropisetron)在抑郁动物模型中发挥积极的行为作用。由于5-HT3和N-甲基-D-天门冬氨酸(NMDA)受体的离子性质,以及它们对抑郁症的病理生理的贡献,我们研究了NMDA受体在5-HT3受体拮抗剂的抗抑郁样作用中的可能作用。在雄性小鼠中。为了评估动物对不同处理的反应行为,我们进行了开放视野测试(OFT),强制游泳测试(FST)和尾部悬吊测试(TST),它们被认为是测量运动活动的有效任务和小鼠的抑郁样行为。我们的数据显示,腹膜内(i.p.)施用托吡司琼(5,10和30 mg / kg)和恩丹西酮(0.01和0.1μg / kg)显着减少了FST和TST的固定时间。同样,将亚有效剂量的托吡司琼(1 mg / kg,腹膜内)或恩丹西酮(0.001μg / kg,腹膜内)与亚有效剂量的NMDA受体拮抗剂,氯胺酮(1 mg / kg,腹膜内)并用,MK-801 (0.05 mg / kg,腹膜内)和硫酸镁(10 mg / kg,腹膜内)减少了FST和TST的固定时间。亚有效剂量的NMDA(NMDA受体激动剂,75 mg / kg,腹膜内)消除了5-HT3拮抗剂对FST和TST的作用,进一步支持了5-HT3与NMDA受体之间的相互作用。这些治疗没有影响OFT中动物的运动行为。最后,我们的研究结果表明,5-HT3拮抗剂对小鼠在FST和TST中应对行为的积极作用至少部分是通过NMDA受体参与介导的。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号